
Alvitrox S 250mg/125mg Injection
Marketer
Alarius Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Alvitrox S 250mg/125mg Injection
Combiflox-S 250mg/125mg Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration should strictly follow a healthcare provider's guidance. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician prior to use. Pregnant or lactating individuals should consult their doctor before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration contribute to faster recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Alvitrox S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Alvitrox S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Alvitrox S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Alvitrox S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Alvitrox S 250mg/125mg Injection works:
Alvitrox S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The addition of Sulbactam, a beta-lactamase inhibitor, safeguards Ceftriaxone's effectiveness by neutralizing enzymes that bacteria use to resist its action.
SAFETY ADVICE
AlcoholSAFE
Alvitrox S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Alvitrox S, 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Alvitrox S 250mg/125mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Alvitrox S 250mg/125mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Alvitrox S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Alvitrox S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Alvitrox S 250mg/125mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Alvitrox S 250mg/125mg Injection :
Omitting a scheduled dose of Alvitrox S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Alvitrox S 250mg/125mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial agents |
